671 results on '"Serra, Massimo"'
Search Results
2. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
3. Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold
4. Rational Design of Highly Selective Sialyllactose‐Imprinted Nanogels
5. Polyglycerol Sebacate Elastomer: A Critical Overview of Synthetic Methods and Characterisation Techniques
6. miR-486-5p expression is regulated by DNA methylation in osteosarcoma
7. A Concise Ring Closing Enyne Metathesis Approach for the Preparation of Functionalized Proline‐Derived Azabicycloalkane Amino Acids.
8. Biology of Osteosarcomas
9. Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
10. Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines
11. Affinity Capillary Electrophoresis as a Tool To Characterize Molecularly Imprinted Nanogels in Solution.
12. Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
13. Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams
14. Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma
15. Biology of Osteosarcomas
16. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma
17. Glycovaccine Design: Optimization of Model and Antitubercular Carrier Glycosylation via Disuccinimidyl Homobifunctional Linker
18. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need
19. Data from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
20. Data from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
21. Supplementary materials from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
22. Supplementary Figure S7 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
23. Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
24. Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
25. Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
26. Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
27. Supplementary Figures 1 - 11 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
28. Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
29. Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
30. Supplementary Data from Prognostic Value of CCN3 in Osteosarcoma
31. Supplementary Data from Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
32. Supplementary Figure 1 from Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling
33. Supplementary Figure 1 from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
34. Supplementary Table 3 from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
35. Supplementary Table 2 from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
36. Supplementary Figure 2 from Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling
37. Supplementary Figure 2 from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
38. Supplementary Table 1 from Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling
39. Supplementary Table 1 from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
40. Synthesis of Aryl Thiocyanates and Aryl Selenocyanates via Visible‐Light Activation of Arylazo Sulfones
41. Data from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
42. Supplementary Figure and Table Legends from Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma
43. cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide Derivative
44. Biology of Osteosarcoma
45. Synthesis of Functionalized Proline‐Derived Azabicycloalkane Amino Acids and Their Applications in Drug Discovery: Recent Advances
46. Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
47. Targeting the Multifaceted Neurotoxicity of Alzheimer's Diseaseby Tailored Functionalisation of the Curcumin Scaffold
48. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing
49. Prognostic Relevance of CCN3 in Bone Sarcomas
50. Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-Scale synthesis, physicochemical characterization and in vitro metabolic stability
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.